| Date | Title | Description |
| 15.07.2026 | Tablet Task Beats Alzheimer’s Clinical Tests in Two Minutes, AAIC Data Show | By Henry Baker
Published: Jul 15 2026, 3:39 PM EDT
Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 08.07.2025 | Cumulus raises £3.25M to advance neuroscience clinical trials through at-home EEG-tech | Irish startup Cumulus Neuroscience has raised £3.25 million for its NeuLogic platform. The startup is focused on advancing neuroscience clinical trials and patient care through improved data and AI.
The NeuLogiq Platform was purpose-built i... |
| 11.07.2024 | Cumulus Neuroscience to Join Bio-Hermes 2 Study with Funding from the Innovate UK Small Business Research Initiative (SBRI) Dementia Mission Project | Funded by a nearly £1.2M (~$1.5M USD) award, this research will enable ongoing validation of AccelADx™, a breakthrough screening test for early detection of Alzheimer's dementia.
BELFAST, Northern Ireland and CAMBRIDGE, Mass., July 11, 2024... |
| 11.06.2024 | Cumulus Neuroscience to Partner with The Digital Medicine Society (DiMe) to Drive Adoption of Digital Endpoints in Clinical Trials | Cumulus to participate in The Digital Health Measurement Collaborative Community (DATAcc) by DiMe project – Building the Business Case for Digital Endpoints – to establish industry benchmarks for evaluating return on investment when utilize... |
| 27.03.2024 | Cumulus Neuroscience Receives Innovate UK Small Business Research Initiative (SBRI) Grant Focused on Clinical Biomarker Tools and Technologies for Dementia | Funded by a nearly £1M (~$1.25M USD) grant, this research will enable development and validation of an artificial intelligence (AI) diagnostic tool that improves the accuracy of blood biomarkers.
Cumulus Neuroscience today announced receipt... |
| 22.03.2024 | 35% of Northern Ireland's funding deals went to women-led startups last year | 65 per cent of Northern Ireland's 72 funding deals last year went to startups with all-male executive teams, according to Catalyst’s Deal Tracker. Of all companies who received funding, 35 per cent had at least one female executive whilst z... |
| 15.03.2024 | Cumulus Neuroscience Announces First Patient Enrolled in AccelADx™ Electroencephalogram (EEG) Study for Early Detection of Alzheimer’s Dementia | NIHR-Funded Study Represents the Largest of its Kind Conducted to Date in Alzheimer’s Dementia
BELFAST, Northern Ireland and CAMBRIDGE, Mass.—March 14, 2024— Cumulus Neuroscience (Cumulus; The Company), a global digital health company focu... |
| 15.03.2024 | Cumulus Neuroscience Announces First Patient Enrolled in AccelADx™ Electroencephalogram (EEG) Study for Early Detection of Alzheimer’s Dementia | NIHR-Funded Study Represents the Largest of its Kind Conducted to Date in Alzheimer’s Dementia
BELFAST, Northern Ireland and CAMBRIDGE, Mass.—March 14, 2024— Cumulus Neuroscience (Cumulus; The Company), a global digital health com... |
| 14.03.2024 | Cumulus Neuroscience Announces First Patient Enrolled in AccelADx Electroencephalogram (EEG) Study for Early Detection of Alzheimer's Dementia | NIHR-Funded Study Represents the Largest of its Kind Conducted to Date in Alzheimer's Dementia.
Cumulus Neuroscience today announced the enrollment of the first patient in a major research collaboration with the Universities of Bath and Bri... |
| 25.01.2024 | Six new investments, portfolio progress and an expanding investment team | Clare Terlouw, Head of LifeArc Ventures, said: “Our portfolio of investments expanded during the year and despite challenging financing conditions in the sector we were pleased to invest in six new companies and to continue to support our e... |
| 25.10.2023 | Cumulus Neuroscience Presents Data at CTAD 2023 Annual Meeting | Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data, presented data at the Clinical Trials on Alzheimer’s Disease (CTAD) Annua... |
| 25.10.2023 | Cumulus Neuroscience Presents Data at CTAD 2023 Annual Meeting | Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient car ... |
| 20.10.2023 | 3 LifeArc Ventures’ portfolio companies celebrated in new report on most innovative life science businesses in UK | With the UK setting its sights on becoming a global life sciences superpower, it has created an environment where scientists are able to push the boundaries of research to create breakthrough science.
Many companies and start-ups have rise... |
| 13.07.2023 | Cumulus Neuroscience Announces Research Collaboration with the Universities of Bath and Bristol on Development of Breakthrough Test for Early Detection of Alzheimer’s Dementia | BELFAST, Northern Ireland and CAMBRIDGE, Mass., July 13, 2023 /PRNewswire/ — Cumulus Neuroscience (Cumulus; The Company), a global digit ... |
| 13.07.2023 | Cumulus Neuroscience Announces Research Collaboration with the Universities of Bath and Bristol on Development of Breakthrough Test for Early Detection of Alzheimer’s Dementia | BELFAST, Northern Ireland and CAMBRIDGE, Mass., July 13, 2023 /PRNewswire/ — Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved da... |
| 11.07.2023 | Cumulus Neuroscience to Present Data at AAIC 2023 Annual Meeting and Technology and Dementia Preconference | BELFAST, Northern Ireland and CAMBRIDGE, Mass., July 11, 2023 /PRNewswire/ — Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved da... |
| 11.07.2023 | Cumulus Neuroscience to Present Data at AAIC 2023 Annual Meeting and Technology and Dementia Preconference | BELFAST, Northern Ireland and CAMBRIDGE, Mass., July 11, 2023 /PRNewswire/ — Cumulus Neuroscience (Cumulus; The Company), a global digit ... |
| 12.04.2023 | Cumulus Neuroscience ExpandsDevelopment Support of NovelPrecision CNS Therapeutics | BELFAST, Northern Ireland and CAMBRIDGE, Mass., April 11, 2023 /PRNewswire/ — Cumulus Neuroscience (Cumulus; TheCompany), a global digital health company focused on advancing neuroscience clinical trials and patient care throughim... |
| 12.04.2023 | Cumulus Neuroscience ExpandsDevelopment Support of NovelPrecision CNS Therapeutics | BELFAST, Northern Ireland and CAMBRIDGE, Mass., April 11, 2023 /PRNewswire/ — Cumulus Neuroscience (Cumulus; TheCompany), a global digital health company focused on advancing neuroscience clinical trials and patient care throughimproved dat... |
| 14.09.2021 | Cumulus Neuroscience Appoints Dr Ruth McKernan CBE as Chair | BELFAST, Northern Ireland, Sept. 14, 2021 /PRNewswire/ -- Cumulus Neuroscience (Cumulus, The Company), a leading global innovator providing real-world clinical trial data and AI-powered insights to accelerate the development of life-changin... |
| 05.05.2021 | Cumulus Neuroscience raises £6m in Dementia Discovery Fund-led financing round | Belfast-headquartered Cumulus Neuroscience has raised £6m in a financing round led by the Dementia Discovery Fund, with the funds set to be used to advance its integrated physiological and digital... |
| 04.05.2021 | LifeArc invests in Cumulus Neuroscience | Life Arc announces it has participated in a £6 million financing round into Cumulus Neuroscience, formerly known as BrainWaveBank. The funding is led by Dementia Discovery Fund (DDF)/SV Health investors and supported by the UK Future Fund.
... |
| 04.05.2021 | Cumulus Neuroscience Raises £6M in Funding | Cumulus Neuroscience, formerly known as BrainWaveBank, a Belfast, UK – based provider of “real-world” clinical trial data and AI-powered insights, raised £6m in funding.
The round was led by the Dementia Discovery Fund (DDF) joined by LifeA... |
| 04.05.2021 | Ireland-based biotech startup Cumulus Neuroscience raises $8.3M in funding to accelerate the development of life-changing CNS therapies for patients | Cumulus Neuroscience (formerly known as BrainWaveBank) is a Belfast, Ireland-based biotech startup developing faster and more effective tools to help solve the biggest healthcare challenges in neurodegeneration and psychiatry. Cumulus has c... |
| 04.05.2021 | LifeArc invests in Cumulus Neuroscience | Life Arc announces it has participated in a £6 million financing round into Cumulus Neuroscience, formerly known as BrainWaveBank. The funding is led by Dementia Discovery Fund (DDF)/SV Health investors and supported by the UK Future Fund.
... |
| 04.05.2021 | LifeArc invests in Cumulus Neuroscience | Life Arc announces it has participated in a £6 million financing round into Cumulus Neuroscience, formerly known as BrainWaveBank. The funding is led by Dementia Discovery Fund (DDF)/SV Health investors and supported by the UK Future Fund.
... |
| 04.05.2021 | Cumulus Neuroscience Announces £6 million Funding Round Led by the Dementia Discovery Fund and joined by LifeArc and UK Future Fund | Belfast, UK - 4 May 2021. Cumulus Neuroscience (Cumulus, The Company), formerly known as BrainWaveBank, announces a £6m financing round led by the Dementia Discovery Fund (DDF) joined by LifeArc, a medical research charity, and the UK Futur... |
| - | Cumulus Neuroscience | “Cumulus Neuroscience ” |
